The chews are NSF Certified for Sport, ensuring full label accuracy, ingredient purity, and the absence of banned substances.
The company believes SlimFast is well-positioned to benefit from increased consumer demand for protein and nutrition supplementation during and after GLP-1 treatment.
The global probiotics industry, currently valued at US$73 billion, is expected to reach US$110 billion by 2030, driven by consumer demand for gut health.
Fibersol may delay hunger, support the production of appetite-regulating hormones such as GLP-1 and peptide YY.
The future of nutrition lies in understanding and harnessing the power of biotics – prebiotics, probiotics, postbiotics, and synbiotics – for gut health.